Exact Mass: 393.0576

Exact Mass Matches: 393.0576

Found 22 metabolites which its exact mass value is equals to given mass value 393.0576, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

6-Methylthioguanosine monophosphate

{[(2R,3S,4R,5R)-3,4-dihydroxy-5-[2-imino-6-(methylsulfanyl)-3,9-dihydro-2H-purin-9-yl]oxolan-2-yl]methoxy}phosphonic acid

C11H16N5O7PS (393.0508)


6-Methylthioguanosine monophosphate is a metabolite of tioguanine. Tioguanine, formerly thioguanine, is a drug that is used in the treatment of cancer. It belongs to the family of drugs called antimetabolites. It is a guanine analog. (Wikipedia)

   

Lorzafone

2-amino-N-({[4-chloro-2-(2-chlorobenzoyl)phenyl](methyl)carbamoyl}methyl)acetamide

C18H17Cl2N3O3 (393.0647)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

6,6-Dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine

4,6-diamino-(1,2-dihydro)-2,2-Dimethyl-1-(2,4,5-trichlorophenoxypropyloxy)-1,3,5-triazine.hcl

C14H18Cl3N5O2 (393.0526)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists

   

5-Hydroxythiabendazole glucuronide

5-Hydroxythiabendazole glucuronide

C16H15N3O7S (393.0631)


   

Sulfaloxic acid

2-[[4-(hydroxymethylcarbamoylsulfamoyl)phenyl]carbamoyl]benzoic acid

C16H15N3O7S (393.0631)


C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

   

4-(4-(4-BROMO-2,6-DIMETHYLPHENYLAMINO)PYRIMIDIN-2-YLAMINO)BENZONITRILE

4-(4-(4-BROMO-2,6-DIMETHYLPHENYLAMINO)PYRIMIDIN-2-YLAMINO)BENZONITRILE

C19H16BrN5 (393.0589)


   

2-amino-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone 4-Methylbenzenesulfonate

2-amino-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone 4-Methylbenzenesulfonate

C16H15F4NO4S (393.0658)


   

platinum acetylacetonate

platinum acetylacetonate

C10H14O4Pt (393.054)


   

6-methoxy-3-methyl-2-[3-methyl-3-(4-nitrophenyl)triazen-1-yl]benzothiazolium chloride

6-methoxy-3-methyl-2-[3-methyl-3-(4-nitrophenyl)triazen-1-yl]benzothiazolium chloride

C16H16ClN5O3S (393.0662)


   

2-[2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazol-4-yl]acetic acid

2-[2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazol-4-yl]acetic acid

C20H15N3O2S2 (393.0606)


   

1H-Isoindol-1-one, 7-bromo-2,3-dihydro-2-[2-[3-(2-pyrimidinyl)phenyl]ethyl]-

1H-Isoindol-1-one, 7-bromo-2,3-dihydro-2-[2-[3-(2-pyrimidinyl)phenyl]ethyl]-

C20H16BrN3O (393.0477)


   
   

2-Methylthio-AMP TEA salt

2-Methylthio-AMP TEA salt

C11H16N5O7PS (393.0508)


2-Methylthio-AMP (2-MeSAMP) is a selective and direct P2Y12 antagonist. 2-Methylthio-AMP is an inhibitor of ADP-dependent platelet aggregation[1][2][3]. 2-Methylthio-AMP (2-MeSAMP) is a selective and direct P2Y12 antagonist. 2-Methylthio-AMP is an inhibitor of ADP-dependent platelet aggregation[1][2][3].

   

N,N-dimethylcarbamothioic acid O-[4-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,6-dimethylphenyl] ester

N,N-dimethylcarbamothioic acid O-[4-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,6-dimethylphenyl] ester

C19H20ClNO2S2 (393.0624)


   

Aluminum nicotinate

Aluminum nicotinate

C18H12AlN3O6 (393.0541)


C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AD - Nicotinic acid and derivatives

   

3-Carboxy-2,7-dihydroxy-9-methoxy-4-methyl-6,11-dioxotetracen-5-olate

3-Carboxy-2,7-dihydroxy-9-methoxy-4-methyl-6,11-dioxotetracen-5-olate

C21H13O8- (393.061)


   

N-[(3-bromo-4-ethoxy-5-methoxyphenyl)methyl]-2,3-dihydro-1,4-benzodioxin-6-amine

N-[(3-bromo-4-ethoxy-5-methoxyphenyl)methyl]-2,3-dihydro-1,4-benzodioxin-6-amine

C18H20BrNO4 (393.0576)


   

Platinum diacetylacetonate

Platinum diacetylacetonate

C10H14O4Pt (393.054)


   

6-Methylthioguanosine monophosphate

6-Methylthioguanosine monophosphate

C11H16N5O7PS (393.0508)


   

(1r,2r,5s,8r)-5-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

(1r,2r,5s,8r)-5-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

C17H19N3O2S3 (393.0639)


   

5-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

5-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

C17H19N3O2S3 (393.0639)


   

(1r,2r,5r,8r)-5-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

(1r,2r,5r,8r)-5-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one

C17H19N3O2S3 (393.0639)